Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-08

FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approved Natco Pharma USA LLC's supplemental application for Diazepam (generic) under ANDA210363. This approval advances the generic Diazepam product for ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)